Skip to content

Heidy King-Jones, Insider at Spyre Therapeutics, sold SYRE on Oct 1, 2026

Data as of Oct 16

▼ SELL$1.5M16,605 shares at $90.35Heidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.
Watch SYRE
Traded
Oct 1, 2026
Disclosed
Oct 2, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Heidy King-Jones, Insider at Spyre Therapeutics, sold SYRE on Oct 1, 2026TRADEDDISCLOSED
SYRESimilar stocks (XLV — its sector index fund), rebased to SYRE's price on the disclosure day
SYRE since disclosure
−14.3%
after the sale
Similar stocks (XLV) since disclosure
+6.3%
XLV — its sector index fund

Change in closing price from Oct 2, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$195Kdisclosed Oct 2 · filed 1 day after the trade
  2. ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$35.7Kdisclosed Oct 2 · filed 1 day after the trade
  3. ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$243Kdisclosed Oct 2 · filed 1 day after the trade
  4. ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$660Kdisclosed Oct 2 · filed 1 day after the trade

See every trade on SYRE →